Literature DB >> 16816390

The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaB.

Amador Albor1, Sally El-Hizawi, Elizabeth J Horn, Melanie Laederich, Patrick Frosk, Klaus Wrogemann, Molly Kulesz-Martin.   

Abstract

Protein inhibitors of activated STATs (PIAS) family members are ubiquitin-protein isopeptide ligase-small ubiquitin-like modifier ligases for diverse transcription factors. However, the regulation of PIAS protein activity in cells is poorly understood. Previously, we reported that expression of Trim32, a RING domain ubiquitin-protein isopeptide ligase-ubiquitin ligase mutated in human limb-girdle muscular dystrophy type 2H (LGMD2H) and Bardet-Biedl syndrome, is elevated during mouse skin carcinogenesis, protecting keratinocytes from apoptosis induced by UVB and tumor necrosis factor-alpha (TNFalpha). Here we report that Trim32 interacts with Piasy and promotes Piasy ubiquitination and degradation. Ubiquitination of Piasy by Trim32 could be reproduced in vitro using purified components. Their interaction was induced by treatment with UVB/TNFalpha and involved redistribution of Piasy from the nucleus to the cytoplasm, where it accumulated in cytoplasmic granules that colocalized with Trim32. Piasy destabilization and ubiquitination required an intact RING domain in Trim32. The LGMD2H-associated missense point mutation prevented Trim32 binding to Piasy, and human Piasy failed to colocalize with human Trim32 in fibroblasts isolated from an LGMD2H patient. Trim32 expression increased the transcriptional activity of NFkappaB in epidermal keratinocytes, both under basal treatment and after UVB/TNFalpha treatment. Conversely, Piasy inhibited NFkappaB activity under the same conditions and sensitized keratinocytes to apoptosis induced by TNFalpha and UVB. Our results indicate that, by controlling Piasy stability, Trim32 regulates UVB-induced keratinocyte apoptosis through induction of NFkappaB and suggests loss of function of Trim32 in LGMD2H.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16816390     DOI: 10.1074/jbc.M601655200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  TRIM32 Drives Pathogenesis in Streptococcal Toxic Shock-Like Syndrome and Streptococcus suis Meningitis by Regulating Innate Immune Responses.

Authors:  Xuan OuYang; Jie Guo; Qingyu Lv; Hua Jiang; Yuling Zheng; Peng Liu; Tongyan Zhao; Decong Kong; Huaijie Hao; Yongqiang Jiang
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

Review 2.  Regulation of the sumoylation system in gene expression.

Authors:  Bin Liu; Ke Shuai
Journal:  Curr Opin Cell Biol       Date:  2008-05-28       Impact factor: 8.382

Review 3.  PIAS proteins: pleiotropic interactors associated with SUMO.

Authors:  Miia M Rytinki; Sanna Kaikkonen; Petri Pehkonen; Tiina Jääskeläinen; Jorma J Palvimo
Journal:  Cell Mol Life Sci       Date:  2009-06-13       Impact factor: 9.261

4.  MicroRNA-155 Reinforces HIV Latency.

Authors:  Debbie S Ruelas; Jonathan K Chan; Eugene Oh; Amy J Heidersbach; Andrew M Hebbeler; Leonard Chavez; Eric Verdin; Michael Rape; Warner C Greene
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

5.  Interaction with the Bardet-Biedl gene product TRIM32/BBS11 modifies the half-life and localization of Glis2/NPHP7.

Authors:  Haribaskar Ramachandran; Tobias Schäfer; Yunhee Kim; Konstantin Herfurth; Sylvia Hoff; Soeren S Lienkamp; Albrecht Kramer-Zucker; Gerd Walz
Journal:  J Biol Chem       Date:  2014-02-05       Impact factor: 5.157

6.  E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis.

Authors:  Ju Liu; C Zhang; X L Wang; P Ly; V Belyi; Z Y Xu-Monette; K H Young; W Hu; Z Feng
Journal:  Cell Death Differ       Date:  2014-08-22       Impact factor: 15.828

7.  TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/STING protein for K63-linked ubiquitination.

Authors:  Jing Zhang; Ming-Ming Hu; Yan-Yi Wang; Hong-Bing Shu
Journal:  J Biol Chem       Date:  2012-06-28       Impact factor: 5.157

8.  TRIM65 regulates microRNA activity by ubiquitination of TNRC6.

Authors:  Shitao Li; Lingyan Wang; Bishi Fu; Michael A Berman; Alos Diallo; Martin E Dorf
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

9.  Upregulated TRIM32 correlates with enhanced cell proliferation and poor prognosis in hepatocellular carcinoma.

Authors:  Xiaopeng Cui; Zhipeng Lin; Yuyan Chen; Xiaofei Mao; Wenkai Ni; Jinxia Liu; Huiling Zhou; Xiaohang Shan; Lingling Chen; Jiale Lv; Zhongyi Shen; Chengwei Duan; Baoying Hu; Runzhou Ni
Journal:  Mol Cell Biochem       Date:  2016-08-30       Impact factor: 3.396

10.  Regulation of the psoriatic chemokine CCL20 by E3 ligases Trim32 and Piasy in keratinocytes.

Authors:  Yuangang Liu; James P Lagowski; Shangpu Gao; James H Raymond; Clifton R White; Molly F Kulesz-Martin
Journal:  J Invest Dermatol       Date:  2010-01-07       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.